Sales & Marketing News | pharmaphorum

News

Australia joins EU in turning down Alzheimer's drug Leqembi

Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy Leqembi, saying its efficacy does not outweigh its risks.

News

FDA set to decide on GSK's gepotidacin antibiotic in March

The FDA has started a priority review of GSK's gepotidacin, which could become the first in a new class of oral antibiotics for uncomplicated urinary tract infections (uUTIs) in over 20 yea

News

GSK turns its guns on Moderna in mRNA jab patent dispute

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV).

News

LEO launches chronic hand eczema drug in its first market

Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE).

News

Baxter medicines in short supply after hurricane hits plant

Damage to a Baxter manufacturing facility caused by Hurricane Helene, which rolled across the east US a couple of weeks ago, has led to shortages in some critical medicines.

News

FDA rethinking block on compounding of Lilly's obesity drug

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide.

Australia joins EU in turning down Alzheimer's drug Leqembi

FDA set to decide on GSK's gepotidacin antibiotic in March

GSK turns its guns on Moderna in mRNA jab patent dispute

LEO launches chronic hand eczema drug in its first market

Baxter medicines in short supply after hurricane hits plant

FDA rethinking block on compounding of Lilly's obesity drug

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks